This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Diagnostic Hybrids, Inc., Health Research, Inc.. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mechanicville, NY (US) (2006)
- Rockville, MD (US) (2010)
Company Filing History:
Years Active: 2006-2010
Title: Laura Gillim-Ross: Innovator in Viral Detection Technologies
Introduction
Laura Gillim-Ross is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of viral detection, particularly in relation to SARS-coronavirus. With a total of two patents to her name, her work has been instrumental in advancing methods for detecting and combating viral infections.
Latest Patents
Laura's latest patents include "Compositions and methods for detecting a non plus-stranded RNA virus" and "Compositions and methods for detecting severe acute respiratory syndrome coronavirus." These inventions provide essential compositions and methods for detecting the presence of SARS-coronavirus. They also facilitate the screening of anti-SARS coronavirus agents and vaccines, aiming to reduce infection rates associated with plus-strand RNA viruses such as SARS-coronavirus.
Career Highlights
Throughout her career, Laura has worked with notable companies such as Diagnostic Hybrids, Inc. and Health Research, Inc. Her expertise in viral detection has positioned her as a key player in the development of innovative solutions for public health challenges.
Collaborations
Laura has collaborated with esteemed colleagues, including Jill Taylor and David R Scholl. These partnerships have further enhanced her research and development efforts in the field of viral detection.
Conclusion
Laura Gillim-Ross is a dedicated inventor whose work in viral detection technologies has made a significant impact on public health. Her innovative patents and collaborations reflect her commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile